Skip to content

{ Tag Archives } Food And Drug Administration Fda

Medicis Announces Approval Of Additional Strengths Of Solodyn(R)

Main Category: Dermatology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 31 Aug 2010 – 1:00 PDT

email to a friend   printer friendly   opinions  
<!–   rate article
Medicis (NYSE:MRX) announced that the U.S. Food and Drug Administration (FDA) has
approved additional strengths of SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets in [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,

Cetero Research Announces Expansion Of TDDS And Dermatology Services To Four Clinical Facilities

Main Category: Dermatology
Also Included In: Medical Devices / Diagnostics
Article Date: 20 Aug 2010 – 2:00 PDT

email to a friend   printer friendly   view / write opinions  
<!–   rate article
Cetero Research, the leading early-stage contract research organization (CRO), announced the expansion of multiple Clinical Dermatology and Transdermal Delivery System (TDDS) [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,

Ipilimumab Receives FDA Priority Review Designation For Adult Patients With Previously Treated Advanced Melanoma

Main Category: Melanoma / Skin Cancer
Also Included In: Regulatory Affairs / Drug Approvals;  Dermatology
Article Date: 20 Aug 2010 – 1:00 PDT

email to a friend   printer friendly   view / write opinions  
<!–   rate article
Bristol-Myers Squibb Company (NYSE: BMY) announced that the U.S. Food and Drug Administration (FDA) has accepted, for [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,

Fibrocell Science, Inc. Completes Enrollment And First Treatment Visits For Histology Study Of Azficel-T

Main Category: Dermatology
Also Included In: Seniors / Aging;  Clinical Trials / Drug Trials;  Pharma Industry / Biotech Industry
Article Date: 10 Jul 2010 – 1:00 PDT

email to a friend   printer friendly   view / write opinions
<!–   rate article

Fibrocell Science, Inc. (OTC Bulletin Board: FCSC), a biotechnology company focused on the development of [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,

Sunscreen Safety And Effectiveness

Main Category: Dermatology
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 25 May 2010 – 1:00 PDT

email to a friend   printer friendly   view / write opinions
<!–   rate article

Sunscreen active ingredients, which are compounds that absorb, scatter or reflect ultraviolet (UV) light, are regulated as over-the-counter (OTC) drugs by [...]

Bookmark and Share Also tagged , , , , , , , , , , , , , , , , , ,

American Academy Of Dermatology Association Testifies At FDA Hearing On Indoor Tanning Devices

American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices…

Bookmark and Share Also tagged , , , , , , , , , , , , , , , ,

Galderma Received FDA Approval Of Differin(R) (adapalene) Lotion, 0.1%, The First Retinoid Available In Lotion Formulation

Galderma Laboratories, L.P. announced the U.S. Food and Drug Administration (FDA) approval of Differin® (adapalene) Lotion, 0.1%, the first-ever lotion formulation of the well-tolerated retinoid adapalene, for the treatment of acne. Differin Lotion, 0.1% will be available by prescription in April 2010. Differin Lotion, 0…

Bookmark and Share Also tagged , , , , , , , , ,

Sizing Up Nanotechnology: How Nanosized Particles May Affect Skin Care Products

The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration (FDA) regarding the safety of this [...]

Bookmark and Share Also tagged , , , , , , , , , , , ,

First Fractional Laser FDA Cleared For Striae

Palomar Medical Technologies, Inc. is pleased to announce that the Lux1540™ Fractional non-ablative laser handpiece has received the first clearance by the United States Food and Drug Administration (FDA) for the treatment of striae (stretch marks) using a fractional laser…

Bookmark and Share Also tagged , , , , , , ,

FDA Issues Complete Response Letter For Ceftobiprole

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for ceftobiprole. The New Drug Application (NDA) was originally submitted to the FDA in May 2007 for the treatment of complicated skin and skin structure infections (cSSSI), including diabetic foot [...]

Bookmark and Share Also tagged , , , , , , , , , , , , ,